Skip to content

Demonstration of the SPECT/CT System With CZT Detectors Imaging Performance in a Clinical Setting

Demonstration of the SPECT/CT System With CZT Detectors Imaging Performance in a Clinical Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03229772
Enrollment
19
Registered
2017-07-26
Start date
2015-09-30
Completion date
2016-05-31
Last updated
2017-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The primary purpose of the study is to obtain sample clinical images that are evaluated by physicians in support of regulatory submissions. Additionally, the study will provide data for current and future product development and it will provide clinical images and data for marketing use.

Interventions

DEVICEDiscovery NM/CT 670 CZT Imaging Scan

At a single visit, subjects will undergo nuclear medicine scintigraphy imaging scanning on the investigational GE Discovery 670 NM/CT CZT (with CZT) device and the commercial GE Discovery 670c (without CZT).

Sponsors

GE Healthcare
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. are 18-years old and older; 2. is able to sign and date the informed consent form; AND 3. have been prescribed by a physician a nuclear medicine exam that is within the intended use of the device.

Exclusion criteria

1. Patients who were referred for dynamic nuclear medicine scan because of the need to be injected twice (once for the conventional acquisition and once for the investigational device) that would result in an increase dose burden on patient. 2. Pregnant or lactating women 3. Who were previously enrolled in this study; 4. Who have contraindication for the radiopharmaceutical 5. Who have any conditions that, in the opinion of the Investigator, would interfere with the evaluation of the results or constitute a health hazard for the subject;

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Image Quality12 weeksDiagnostic Image Quality will be rated by 2 radiologist using a 5 point Likert Scale
Image Resolution12 weeksImage Resolution will be rated by 2 radiologist using a 5 point Likert Scale

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026